Durvalumab is a monoclonal antibody medication used to treat various types of cancer. It is used in combination with other medications to treat certain types of non-small cell lung cancer, bladder cancer, head and neck cancers, and Hodgkin lymphoma. Durvalumab works by targeting a protein called PD-L1 on cancer cells, which helps the cancer cells to evade the immune system. This makes it easier for the immune system to destroy the cancer cells. Durvalumab is given as an intravenous infusion and is usually taken once every two to four weeks. Common side effects include fatigue, nausea, and decreased appetite.
Durvalumab, sold under the brand name Imfinzi, is a medication used to treat certain types of cancer [1]. It falls under the category of immunotherapy, also referred to as an immune checkpoint inhibitor [2, 3].
Here's a breakdown of how Durvalumab works:
- Immunotherapy: It harnesses the body's own immune system to fight cancer cells [2, 3].
- Immune Checkpoint Inhibitor: Certain proteins on immune cells (like PD-1) and cancer cells (like PD-L1) can act as checkpoints, preventing the immune system from attacking the cancer. Durvalumab blocks the interaction between PD-L1 and PD-1, essentially taking the brakes off the immune system and allowing it to recognize and destroy cancer cells [2, 3, 5].
Conditions treated with Durvalumab:
- Non-Small Cell Lung Cancer (NSCLC):
- Inoperable NSCLC that hasn't worsened after initial treatment [2].
- Extensive-stage NSCLC, in combination with other medications [2, 4].
- Hepatocellular Carcinoma (HCC): In combination with another medication, for HCC that cannot be removed with surgery [2].
Important things to remember about Durvalumab:
- It's a prescription medication and should only be taken under a doctor's supervision [2].
- There can be serious side effects, as Durvalumab can cause the immune system to attack healthy organs and tissues [4].
- It's not for everyone and your doctor will determine if it's the right treatment for you based on your specific condition [2].
If you have any further questions about Durvalumab, it's important to consult with a healthcare professional.